| UniProt ID | MPH6_HUMAN | |
|---|---|---|
| UniProt AC | Q99547 | |
| Protein Name | M-phase phosphoprotein 6 | |
| Gene Name | MPHOSPH6 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 160 | |
| Subcellular Localization | Nucleus, nucleolus. Cytoplasm. Cytoplasmic in M phase. | |
| Protein Description | RNA-binding protein that associates with the RNA exosome complex. Involved in the 3'-processing of the 7S pre-RNA to the mature 5.8S rRNA and may play a role in recruiting the RNA exosome complex to pre-rRNA; this function may include C1D.. | |
| Protein Sequence | MAAERKTRLSKNLLRMKFMQRGLDSETKKQLEEEEKKIISEEHWYLDLPELKEKESFIIEEQSFLLCEDLLYGRMSFRGFNPEVEKLMLQMNAKHKAEEVEDETVELDVSDEEMARRYETLVGTIGKKFARKRDHANYEEDENGDITPIKAKKMFLKPQD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 11 | Ubiquitination | ERKTRLSKNLLRMKF HHHHHHHHHHHHHHH | 57.09 | - | |
| 11 | Sumoylation | ERKTRLSKNLLRMKF HHHHHHHHHHHHHHH | 57.09 | - | |
| 11 | Sumoylation | ERKTRLSKNLLRMKF HHHHHHHHHHHHHHH | 57.09 | - | |
| 17 | Acetylation | SKNLLRMKFMQRGLD HHHHHHHHHHHCCCC | 31.11 | 24468261 | |
| 17 | Ubiquitination | SKNLLRMKFMQRGLD HHHHHHHHHHHCCCC | 31.11 | - | |
| 25 | Phosphorylation | FMQRGLDSETKKQLE HHHCCCCHHHHHHHH | 52.81 | 21712546 | |
| 27 | Phosphorylation | QRGLDSETKKQLEEE HCCCCHHHHHHHHHH | 47.71 | 29083192 | |
| 37 | Sumoylation | QLEEEEKKIISEEHW HHHHHHHHHCCCHHH | 48.85 | 28112733 | |
| 45 | Phosphorylation | IISEEHWYLDLPELK HCCCHHHCCCCHHHH | 7.70 | 27642862 | |
| 52 | Ubiquitination | YLDLPELKEKESFII CCCCHHHHHHHCEEE | 66.14 | - | |
| 54 | Ubiquitination | DLPELKEKESFIIEE CCHHHHHHHCEEECH | 58.01 | - | |
| 76 | Phosphorylation | DLLYGRMSFRGFNPE HHHHCCCCCCCCCHH | 15.49 | 24719451 | |
| 86 | Sumoylation | GFNPEVEKLMLQMNA CCCHHHHHHHHHHHH | 44.35 | 28112733 | |
| 86 | Ubiquitination | GFNPEVEKLMLQMNA CCCHHHHHHHHHHHH | 44.35 | 21906983 | |
| 96 | Ubiquitination | LQMNAKHKAEEVEDE HHHHHHCCCHHHCCC | 57.71 | - | |
| 104 | Phosphorylation | AEEVEDETVELDVSD CHHHCCCCEEECCCH | 31.44 | 30266825 | |
| 110 | Phosphorylation | ETVELDVSDEEMARR CCEEECCCHHHHHHH | 38.68 | 30266825 | |
| 118 | Phosphorylation | DEEMARRYETLVGTI HHHHHHHHHHHHHHH | 14.01 | 28796482 | |
| 120 | Phosphorylation | EMARRYETLVGTIGK HHHHHHHHHHHHHHH | 20.15 | 23312004 | |
| 124 | Phosphorylation | RYETLVGTIGKKFAR HHHHHHHHHHHHHHH | 21.05 | 25159151 | |
| 127 | Ubiquitination | TLVGTIGKKFARKRD HHHHHHHHHHHHHCC | 40.65 | 21906983 | |
| 127 | Acetylation | TLVGTIGKKFARKRD HHHHHHHHHHHHHCC | 40.65 | 25953088 | |
| 127 | 2-Hydroxyisobutyrylation | TLVGTIGKKFARKRD HHHHHHHHHHHHHCC | 40.65 | - | |
| 127 | Sumoylation | TLVGTIGKKFARKRD HHHHHHHHHHHHHCC | 40.65 | 28112733 | |
| 128 | Ubiquitination | LVGTIGKKFARKRDH HHHHHHHHHHHHCCC | 38.76 | - | |
| 132 | Ubiquitination | IGKKFARKRDHANYE HHHHHHHHCCCCCCC | 59.76 | - | |
| 138 | Phosphorylation | RKRDHANYEEDENGD HHCCCCCCCCCCCCC | 22.83 | 27642862 | |
| 147 | Phosphorylation | EDENGDITPIKAKKM CCCCCCCCCCCCCCC | 24.57 | 22167270 | |
| 150 | Sumoylation | NGDITPIKAKKMFLK CCCCCCCCCCCCCCC | 56.19 | 28112733 | |
| 150 | Ubiquitination | NGDITPIKAKKMFLK CCCCCCCCCCCCCCC | 56.19 | 21906983 | |
| 150 | Acetylation | NGDITPIKAKKMFLK CCCCCCCCCCCCCCC | 56.19 | 25953088 | |
| 150 | Sumoylation | NGDITPIKAKKMFLK CCCCCCCCCCCCCCC | 56.19 | - | |
| 153 | Sumoylation | ITPIKAKKMFLKPQD CCCCCCCCCCCCCCC | 39.48 | 25772364 | |
| 153 | Ubiquitination | ITPIKAKKMFLKPQD CCCCCCCCCCCCCCC | 39.48 | - | |
| 153 | Methylation | ITPIKAKKMFLKPQD CCCCCCCCCCCCCCC | 39.48 | 110868535 | |
| 153 | Sumoylation | ITPIKAKKMFLKPQD CCCCCCCCCCCCCCC | 39.48 | - | |
| 157 | Ubiquitination | KAKKMFLKPQD---- CCCCCCCCCCC---- | 29.39 | - | |
| 157 | Acetylation | KAKKMFLKPQD---- CCCCCCCCCCC---- | 29.39 | 22424773 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MPH6_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MPH6_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MPH6_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ERG28_HUMAN | C14orf1 | physical | 16169070 | |
| APLP1_HUMAN | APLP1 | physical | 16169070 | |
| RBM48_HUMAN | RBM48 | physical | 16169070 | |
| GDF9_HUMAN | GDF9 | physical | 16169070 | |
| LRIF1_HUMAN | LRIF1 | physical | 16169070 | |
| U119A_HUMAN | UNC119 | physical | 16169070 | |
| ZHX1_HUMAN | ZHX1 | physical | 16169070 | |
| TLE1_HUMAN | TLE1 | physical | 16169070 | |
| P53_HUMAN | TP53 | physical | 16169070 | |
| PRPF3_HUMAN | PRPF3 | physical | 22939629 | |
| EXOSX_HUMAN | EXOSC10 | physical | 26344197 | |
| EXOS2_HUMAN | EXOSC2 | physical | 26344197 | |
| EXOS3_HUMAN | EXOSC3 | physical | 26344197 | |
| EXOS4_HUMAN | EXOSC4 | physical | 26344197 | |
| EXOS6_HUMAN | EXOSC6 | physical | 26344197 | |
| EXOS9_HUMAN | EXOSC9 | physical | 28877463 | |
| EXOS7_HUMAN | EXOSC7 | physical | 28877463 | |
| EXOS8_HUMAN | EXOSC8 | physical | 28877463 | |
| EXOS3_HUMAN | EXOSC3 | physical | 28877463 | |
| EXOS2_HUMAN | EXOSC2 | physical | 28877463 | |
| EXOS6_HUMAN | EXOSC6 | physical | 28877463 | |
| EXOS5_HUMAN | EXOSC5 | physical | 28877463 | |
| EXOS4_HUMAN | EXOSC4 | physical | 28877463 | |
| EXOS1_HUMAN | EXOSC1 | physical | 28877463 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-110 AND THR-147, ANDMASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-147, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-147, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-147, AND MASSSPECTROMETRY. | |